Skip to main content
. 2014 Oct 2;8(6):2790–2794. doi: 10.3892/ol.2014.2583

Table I.

Exclusion criteria.

Patients, n

Criterion GU CGDU
Gastric cancer 697 11
Lymphoma 32 0
History of anti-H. pylori therapy 257 43
Treatment with NSAIMs, H2-receptor antagonists or proton pump inhibitors 736 179

GU, gastric ulcer; CGDU, concomitant gastric and duodenal ulcer; H. pylori, Helicobacter pylori; NSAIMs, non-steroidal anti-inflammatory medicines.